Compare Rockwell Automation (ROK) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rockwell Automation vs Zoetis Inc — how do they compare? Rockwell Automation trades at $432.59 (market cap $48.21B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Rockwell Automation is the larger of the two by market cap, and Zoetis Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals — on Pluang, investors hold Rockwell Automation for 74 Days and Zoetis Inc for 70 Days on average.
| ROK | ZTS | |
|---|---|---|
Market Cap | $48.21B | $30.20B |
Volume | 953,342 | 6,175,327 |
Sector | Industrials | Health |
52-Week High | $495.08 | $147.53 |
52-Week Low | $333.75 | $69.09 |
Typical Hold Time | 74 Days | 70 Days |
Enterprise Value | $51.34B | $37.76B |
Dividend Yield | 1.27% | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Rockwell Automation (ROK) trades at $434.14, down 1.76% on the day, with a bearish technical signal and neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $3.49 exceeding the $3.38 estimate. Fundamentals show robust profitability with a 34.47% ROE and 13.38% net income margin, though valuation ratios like a P/E of 40.65 appear elevated. Recent news highlights leadership in industrial automation and digital transformation, including partnerships in AI-enabled cyber defense.
The outlook for ROK is mixed, with analyst consensus leaning hold (68.29%) but a price target of $489.89 implying potential upside. Key opportunities include sustained demand for automation solutions, while risks involve high valuation, competitive pressures, and macroeconomic uncertainty. Earnings growth and execution on digital initiatives are critical for driving shareholder value.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal but mixed earnings history including a recent Q1 2026 miss. The stock shows strong profitability with a 27.69% net income margin and 64.91% ROE, while valuation metrics like a P/E of 11.92 appear reasonable. Recent news highlights competitive pressures in the U.S. pet care market, though international segments remain resilient.
The outlook is cautiously optimistic; ZTS faces near-term headwinds from weak U.S. demand and competition, but its industry-leading margins and dominant market position support long-term growth. Risks include pricing erosion and guidance cuts, yet the consensus price target of $87.33 suggests upside potential for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Rockwell Automation
Rockwell Automation is a pure-play automation competitor that is the successor entity to Rockwell International, which spun off its former Rockwell Collins avionics segment in 2001. As of fiscal 2021, the firm operates through three segments--intelligent devices, software and control, and lifecycle services. Intelligent devices contains its drives, sensors, and industrial components, software and control contains its information and network and security software, while lifecycle services contains its consulting and maintenance services as well as its Sensia JV with Schlumberger.
Read more on ROK →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
